Worldwide and China Automotive Connector Industry Report, 2012

The report highlights the followings:

1. Global and China Automobile Market
2. Global and China Automobile Industry Pattern
3. Automotive Wiring Harness and Connector Market
4. 11 Leading Automotive Connector Manufacturers

The automotive connector market size approximated USD10.69 billion in 2012, an increase of 5.1% from a year earlier, and the figure in 2013 will reach USD11.029 billion with a growth rate of 3.2%.

Automotive connector has close bearing on automotive wiring harness since the direct customers of automotive connector are the producers of automotive wiring harness instead of the automakers. Automotive wiring harness manufacturers can produce automotive connectors internally and they also can make procurement from the outside. It is clear that, for automotive wiring harness manufacturers, internal production can to some extent improve both profitability and market share.

Buy a copy of this report @ http://www.reportsnreports.com/reports/215148-global-and-china-automotive-connector-industry-report-2012-.html

As the largest automotive wiring harness manufacturer with the market share of 32% in the world, YAZAKI has always been making efforts to raise the ratio of internal production of connectors. SEI, short for Sumitomo Electric Industries, is the global second largest producer of automotive wiring harness, holding a market share of 25%, but its internal production of connectors accounts for a small proportion, which also restricts the development of the company. The gap between SEI and YAZAKI is being widened.

DELPHI is the fourth largest manufacturer of automotive connectors around the globe. In order to narrow the gap, Delphi acquired the MVL of FCI in May, 2012 and outperformed YAZAKI to become the world’s second largest automotive connector producer. This favors Delphi to sweep more market share in automotive wiring harness field.

JAE and HIROSE, the two Japanese players, are developing fast, mainly fuelled by Japan-based SEI; however, the two which are professional in the fields of mobile phone and notebook have been squeezed by the peers from Taiwan and have to greatly explore automotive connector business.

Molex is focused on mobile phone and telecom sectors, but it also has started to attach importance to automotive sector in recent years. Amphenol is mainly involved in the areas of telecom, IT and mobile phone. We believe SEI’s acquisition on the automotive connector business of Amphenol is a very good choice.

KET is a South Korea-based company with the share participation of YAZAKI and with Hyundai Motors as its key customer. Bolstered by rapid progression of Hyundai Motors, KET’s market share grows steadily.

Request a Sample of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=215148.

Contact sales@reportsandreports.com for further information.

Global DNA Sequencing Market Analysis

This study will be of particular interest to life-science research tools suppliers, pharmaceutical, diagnostics, nanotechnology, bioinformatics, semiconductor, and biotechnology companies.  It will also be valuable to companies involved in genome sequencing projects, sequencing centers, manufacturers of microarrays, suppliers of molecular diagnostics assays, bioinformatics companies, and cancer researchers and clinicians.  As this report is a profiling of top companies in the DNA sequencing field, the main audience should also include executive management personnel and marketing and financial analysts.

The narrative is understood by only those select few who have the cross discipline knowledge to comprehend what the sequencing tools output, and who also have the niche domain experience to act upon knowledge of that data.  Recently, this story has begun to change as low cost next generation sequencing democratizes genome data, allowing a politics and commerce of inclusion, to enter the lab and now also the clinic.

Diagnostic manufacturers can now afford to develop sequencing tools as diagnostic shortcuts.  The clinician does not need to understand the mathematical underpinnings of 16SrRNA coverage for phylogeny to run a rapid anthrax test.

Tandem repeats and retrotransposons have been conveniently converted into a “plus” or “minus” sign a red light/green light clinical decision.

When Watson and Crick let the genie out of the research bottle, it was inevitable that this day would arrive—the only question was when it would happen.  The types of automation that enabled cost efficiencies in sequencing tools have become decision tree shortcuts in the clinic, whereupon the first tangible fruits from the promise of personalized medicine have become apparent.

More information @ http://www.reportsnreports.com/reports/195954-top-ten-companies-in-dna-sequencing.html

DNA sequencing is a strategic genomics tool that allows us to study how the genome varies among individuals and how that variation correlates to disease.  Sequencing technologies are a critical part of today’s life-science industry, affecting a wide range of activity from drug discovery to diagnostics.  This focused document profiles the top 10 companies of the industry and explores the underlying technologies driving the industry’s growth.  Each technology is analyzed to determine its market status, impact on future market segments, and future growth potential.  It should be noted that sequencing costs may only contribute 10% to 20% of a typical biomedical projects overall costs.

Of significance is the large occurrence of collaboration and co-ownership among the top players.  Certain individuals, such as Mike Hunkapller and George Church, appear and reappear in several of the leading companies as co-founder, adviser or board member.  But investment in seemingly rival efforts is also unusually high, underscoring both the connected nature of the research and commercial community, and also a “quantitative easing” or de-risking of being on the right team when the eventual winners are crowned in this high stakes field.

For this top 10 report, many factors were considered when selecting the companies.  In general, chosen companies have a solid foundation built around their sequencing technology and have done an excellent job strategically positioning themselves into one (or many) of the facets of the industry.

In a reply to BCC from one of the top sequencing industry leaders, George Church explains in more detail some of the technological specifics to success.  Next generation sequencing (NGS) systems are evolving rapidly, meaning this should be a core area of focus for a company should they want to excel now and in the near future.

Of the NGS systems, benchtop sequencers have a good niche currently.  Although they can’t process as much as the larger high-throughput systems, being smaller has its obvious advantages.  In the long term, benchtop sequencers may end up getting squeezed out of their niche however, finding no room for successful commercialization between the large high-throughput systems and handheld or portable sequencers which are based around nanopore technology.

At this stage there are several different approaches different companies are working on concerning nanopore-based technologies.  Leading the way in this sector of sequencing will certainly help strengthen any company and their competitive position.  Many companies are competing, and to a certain extent this is a race of scaling, that is, who can get the most nanopores into the smallest area.

One of the problems that arise from the sequencing process is the flood of data that results.  A key issue to note is just how well informatics will be able to handle this data flood.  As read lengths become longer and more accurate, the informatics becomes easier.  Interpretation of the data is another issue that arises, but focusing on medically actionable determinations should simplify rather than complicate the interpretation of results.

Another point to consider is whole genome sequencing, a goal for many.  Applications from this process becoming available everywhere at low cost aren’t too far into the future at the moment.  One application has already emerged, a test for 2,400 highly predictive medical genetic diseases.  This is superior to exome testing as these have the serious flaw of missing phasing information.  For example, if a genome has mutations on say exon number 2 and exon number 7 of a gene, the exome doesn’t distinguish between two hits in one gene copy  (the other copy is fine) vs. hits in both copies (no healthy copies).

Given these criteria to success, along with other factors which BCC chose to examine, BCC has selected these 10 companies for this report that we feel are deserving of recognition and are leaders in their industry, This list includes:

• Agilent Technologies Inc.
• Genia
• International Business Machines Corp.
• Illumina Inc.
• Knome Inc.
• Life Technologies
• Oxford Nanopore Technologies
• Pacific Biosciences
• Raindance Technologies Inc.
• Roche Holding AG.

As any top 10 list is invariably subjective, there are also several companies profiled in less detail.  These companies were on the bubble, or should be watched in the near future.

STUDY GOALS AND OBJECTIVES

This document is a specialty report related to the BCC Research report BIO045D authored by John Bergin.  The goal of this document is to provide a more in-depth look at the top tier DNA sequencing companies as well as some of the second tier companies to look for in the near future, and to note the technological changes within the DNA sequencing industry that are sure to play a role in the years to come.

More specifically, the objectives include identifying companies that are considered the leaders in their field and the technological means these companies are using to exploit their markets and dominate their field. 

Contact: sales@reportsandreports.com for further information.

Industry Reports | Global Enterprise Content Management Market

ReportsnReports add new market research report" Global Enterprise Content Management Market" to its database. The enterprise content management (ECM) market is witnessing continued upward growth, with gradually increasing market revenue anticipated in the current year and over the next few years. Frost & Sullivan defines an ECM as a large-scale, multi-functional, cross-platform content management system (CMS), designed to address the complex content management needs of enterprise-level organizations. Today’s ECM solutions are structural platforms meant to enable and deliver content efficiencies on a wide scale and with the express intent of energizing digital content assets throughout their life cycles. An ECM platform helps companies create a uniform communications layer or a reference architecture layer designed to facilitate cross-platform interoperability, data sharing, and anytime, anywhere secure access to critical company information and content. Many ECM solutions allow for real-time collaboration, massive customization, and content management schemes that empower knowledge workers on a global scale.

This study is Frost & Sullivan's third analysis of the ECM market in the last four years. In this dynamic market characterized as competitive, competent, and innovative, ECM vendors have found their message, a compelling ECM value proposition, and an expanding addressable market. Frost & Sullivan expects that recent technology developments, overall digital media trends, and an increasingly diverse set of capabilities bode well for the CMS marketplace. A broadening marketplace, increasing demand for the efficiencies of digitization and performance accountability, increasing global uptake, and a focus on providing the functionality that customers demand bodes particularly well for the ECM market.

Buy your report copy on @ http://www.reportsnreports.com/reports/156836-global-enterprise-content-management-market.html

Report Details:

Published : April 2012

No. of Pages: 61 Price   

Price : Single User License: US$  6000

In this study, Frost & Sullivan discusses the evolving definition of an ECM solution, the widening customer base, and the vibrant vendor landscape. We dive deep into why companies should consider and acquire ECM solutions as opposed to less-robust content management systems and provide real-world examples of how deployed ECM solutions are helping enable enterprises to optimally manage their content, user accounts, and processes, consequently gaining a competitive market advantage. This study includes an analysis of market growth drivers and restraints, larger digital media, CMS trends and their  anticipated effect on the ECM marketplace, as well as individual market vertical revenue trends.

This study also includes an analysis of market sizing, revenue forecasts, and vendor market shares. We anticipate that the overall global ECM revenue will add up to $2,750 million in 2011, and reach $7,919.5 million by 2017, the end of the forecast period. Pricing, distribution, and unit projections are also discussed herein.

Sixteen independent ECM vendors are discussed in this analysis, including the top five revenue earners in 2011 - OpenText, EMC, Oracle, IBM, and HP (Autonomy). Overall, the top five vendors accounted for more than 80 percent of market revenue in 2011. That said, innovations and creative solutions are being provided throughout the industry, which is at a stage of fairly rapid growth. If it weren’t for the continued economic insecurity in Europe and elsewhere, the growth is this market would probably be higher. Frost & Sullivan has observed that as the industry has rallied around ECM as a productivity architecture and solution, the market is embracing ECM more assertively than before, and growth trends look very positive.